LYT-200

DB18179InvestigationalProtein Based Therapies

LYT-200 is a fully human IgG4 monoclonal antibody directed against galectin-9.

Mechanism
Curator reviewed
Code names
LYT-200

Resolves to

Targets
O00182LGALS9

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with LYT-200, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In